MedTrace Logo

Relationship Between the VEGF Gene Polymorphism and Cardiometabolic Risk Factors

NCT04077554 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2020-06-04

No results posted yet for this study

Summary

The aim of the study is to determine the relationship between VEGF gene expression, VEGF gene polymorphism and serum leptin concentration in the Polish population in people with excessive body weight. In addition, the aim of the study is to look for relationships between the VEGF gene polymorphism and anthropometric and biochemical factors of cardiovascular risk and endothelial dysfunction such as body weight, waist circumference, serum total cholesterol, LDL, HDL, triglycerides, glucose and the occurrence of cardiovascular diseases in the family of a patient with excessive body weight in the Polish population.

Conditions

  • Polymorphism, Restriction Fragment Length

Interventions

GENETIC

gene expression

determination of VEGF gene expression, VEGF gene polymorphism and serum leptin concentration

Sponsors & Collaborators

  • Poznan University of Medical Sciences

    lead OTHER

Principal Investigators

  • Damian Skrypnik, MD; PhD · Poznan University of Medical Sciences

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2018-01-01
Completion
2019-08-30

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04077554 on ClinicalTrials.gov